Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BL-0020 by Shanghai Best-Link Bioscience for Pancreatic Cancer: Likelihood of Approval
BL-0020 is under clinical development by Shanghai Best-Link Bioscience and currently in Phase I for Pancreatic Cancer. According to GlobalData,...
BL-0020 by Shanghai Best-Link Bioscience for Small-Cell Lung Cancer: Likelihood of Approval
BL-0020 is under clinical development by Shanghai Best-Link Bioscience and currently in Phase I for Small-Cell Lung Cancer. According to...
BL-0020 by Shanghai Best-Link Bioscience for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
BL-0020 is under clinical development by Shanghai Best-Link Bioscience and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According...